Atossa Therapeutics
ATOS
ATOS
49 hedge funds and large institutions have $14.2M invested in Atossa Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
56% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 18
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
49
Holding in Top 10
–
Calls
$1.06M
Puts
$66K
Top Buyers
| 1 | +$254K | |
| 2 | +$73.1K | |
| 3 | +$57.4K | |
| 4 |
Squarepoint
New York
|
+$45.4K |
| 5 |
Renaissance Technologies
New York
|
+$30.1K |
Top Sellers
| 1 | -$138K | |
| 2 | -$64.8K | |
| 3 | -$59K | |
| 4 |
VF
Virtu Financial
New York
|
-$59K |
| 5 |
Bank of New York Mellon
New York
|
-$42.2K |